RE:Excluding the Pending Study 2 Data on 27 patients It looks like the first bar graph at 90 days includes only patients 13-24 Hence 1 patient is 8.3%. So 33% CR is 4 out of 6 plus one out of 6 is PR and one out of 6 was NR patient who passed away but had a 95% chance of being CR as per negative predictive value of a negative urine cytology. IMO so 67%-100% CR potential based on those 6 patients at 90 days. Afterwards 180 days on it looks like graphs include those 12 patients plus the outcome of 3 from the 1st set of 12 who received an optimized maintenance treatment at 6 months mark ( after August 2020 optimization) All IMO do your DD, but this is very very encouraging to me.
cashascars wrote: Here is my math when you exclude the Pending and only include the examined patients at each interval.
90 days---- 61.9% CR+PR
180 days---55.5% CR+PR
270 days---41.2% CR+PR
360 days---37.5% CR+PR
450 days----28.6% CR+PR
And as you know the numbers will only get better because the original 12 undertreated
are incuded in this calculation.
These are great numbers and for the simplicity of the procedure we are on our way to becomeing the gold standard baby!
All this is in my own head and that could be the only problem.
cashascars